GeneQuantum and AIMEDBIO Collaborate on a First-in-Class Antibody -Drug-Conjugate ...Middle East

SUZHOU, China, April 18, 2022 /PRNewswire/ -- GeneQuantum Healthcare (Suzhou) Co., Ltd., a company specializing in site-specific bioconjugation for next generation biotherapeutics, has signed an agreement with a Korean biotech company, Aimed Bio Inc., to co-develop a First-in-Class...

Hence then, the article about genequantum and aimedbio collaborate on a first in class antibody drug conjugate was published today ( Tuesday 19/04/2022 - 04:29 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( GeneQuantum and AIMEDBIO Collaborate on a First-in-Class Antibody -Drug-Conjugate )

Also on site :

• Britney Spears Spends Time With Diane Warren and Molly Shannon After DUI
• 'You should resign': Mamata hits out at PM Modi's silence on Pakistan's threat to strike Kolkata
• This Guitarist Helped Shape One of the Most Iconic Sounds of the '90s